JavaScript seems to be disabled in your browser. You must have JavaScript enabled in your browser to utilize the functionality of this website.
Description: Vesatolimod (formerly known as GS-9620) is a novel potent, selective and orally bioactive small molecule agonist of Toll-like receptor 7 (TLR-7) with an EC50 of 291 nM. It has the potential for the treatment of chronic hepatitis B viral (HBV) infection. GS-9620 selectively induces IFN-alpha, cytokines and chemokines. The minimum effective concentrations for IFN-alpha induction were similar in pDCs and in PBMCs from HCV-positive donors. GS-9620 demonstrates an EC50 of 291 nM for human TLR7, which is 30-fold selectivity over TLR8 with EC50 of 9 uM.
References: Cardiol Rev. 2010 Sep-Oct; 18(5):264-7; J Clin Invest. 2001 Jun; 107(11):1423-32.
Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.
All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.
Request Data Sheet
Request product datasheet
Request safety datasheet
Delivery expected until 9/6/2024
Compare
Add to wishlist
Recommend by mail
Get an offer
Request delivery time
Ask a technical question
Submit a bulk request
sales@hoelzel.de
« Back
Subscribe, get 15% off every fifth order and have your items delivered on time!
Forgot Your Password?
Not yet registered? Create account here!